Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $831000.0.

  • Arcadia Biosciences' Receivables - Net fell 578.23% to $831000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $831000.0, marking a year-over-year decrease of 578.23%. This contributed to the annual value of $1.2 million for FY2024, which is 13221.34% up from last year.
  • Latest data reveals that Arcadia Biosciences reported Receivables - Net of $831000.0 as of Q3 2025, which was down 578.23% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Receivables - Net ranged from a high of $3.9 million in Q2 2022 and a low of $304000.0 during Q3 2023
  • Its 5-year average for Receivables - Net is $1.3 million, with a median of $1.1 million in 2021.
  • In the last 5 years, Arcadia Biosciences' Receivables - Net soared by 28954.42% in 2021 and then crashed by 8884.81% in 2023.
  • Arcadia Biosciences' Receivables - Net (Quarter) stood at $1.4 million in 2021, then fell by 12.41% to $1.2 million in 2022, then tumbled by 57.83% to $506000.0 in 2023, then skyrocketed by 132.21% to $1.2 million in 2024, then decreased by 29.28% to $831000.0 in 2025.
  • Its last three reported values are $831000.0 in Q3 2025, $1.3 million for Q2 2025, and $1.6 million during Q1 2025.